PMG Pharm Co., Ltd   Report issue

For profit Phase 3 Phase 4
Founded: Ansan-si Korea, Republic of (2001)
Status: No NME R&D (2001)

Organization Overview

First Clinical Trial
2010
NCT01576419
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

PMG Pharm Co., Ltd

Active Ingredients

Drugs in Phase 4 Trials (2)

cyproviron (2 trials)

nabumetone (relafen) (1 trial)

Drugs in Phase 3 Trials (2)

celecoxib (celebrex) (1 trial)

pk101 (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 1)

Osteoarthritis (Phase 4)

Osteoarthritis, Knee (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 4